Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    GoodRx Inc.

    NASDAQ: GDRX · Real-Time Price · USD
    4.44
    0.07 (1.60%)
    At close: Jun 16, 2025, 3:59 PM
    4.42
    -0.57%
    After-hours: Jun 16, 2025, 07:32 PM EDT

    GoodRx Statistics

    Share Statistics

    GoodRx has 357.17M shares outstanding. The number of shares has increased by 2.24% in one year.

    Shares Outstanding

    n/a
    		 357.17M

    Shares Change (YoY)

    n/a
    		 2.24%

    Shares Change (QoQ)

    n/a
    		 0.65%

    Owned by Institutions (%)

    n/a
    		 35.81%

    Shares Floating

    n/a
    		 296.19M

    Failed to Deliver (FTD) Shares

    n/a
    		 452

    FTD / Avg. Volume

    n/a
    		 0.03%

    Short Selling Information

    The latest short interest is 4.29M, so 1.19% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.29M

    Short % of Shares Out

    n/a
    		 1.19%

    Short % of Float

    n/a
    		 4.7%

    Short Ratio (days to cover)

    n/a
    		 4.72

    Valuation Ratios

    The PE ratio is 109.44 and the forward PE ratio is 9.48. GoodRx's PEG ratio is -0.38.

    PE Ratio

    n/a
    		 109.44

    Forward PE

    n/a
    		 9.48

    PS Ratio

    n/a
    		 2.26

    Forward PS

    n/a
    		 1.5

    PB Ratio

    n/a
    		 2.48

    P/FCF Ratio

    n/a
    		 15.8

    PEG Ratio

    n/a
    		 -0.38
    Financial Ratio History

    Enterprise Valuation

    GoodRx has an Enterprise Value (EV) of 1.89B.

    EV / Sales

    n/a
    		 2.38

    EV / EBITDA

    n/a
    		 12.27

    EV / EBIT

    n/a
    		 10.27

    EV / FCF

    n/a
    		 16.63

    Financial Position

    The company has a current ratio of 5.32, with a Debt / Equity ratio of 0.75.

    Current Ratio

    n/a
    		 5.32

    Quick Ratio

    n/a
    		 5.32

    Debt / Equity

    n/a
    		 0.75

    Debt / EBITDA

    n/a
    		 3.53

    Debt / FCF

    n/a
    		 4.79

    Interest Coverage

    n/a
    		 1.24

    Financial Efficiency

    Return on Equity is 2.26% and Return on Invested Capital is 2.69%.

    Return on Equity

    n/a
    		 2.26%

    Return on Assets

    n/a
    		 1.18%

    Return on Invested Capital

    n/a
    		 2.69%

    Revenue Per Employee

    n/a
    		 $1,073,609.76

    Profits Per Employee

    n/a
    		 $22,208.67

    Employee Count

    n/a
    		 738

    Asset Turnover

    n/a
    		 0.57

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 15.07M

    Effective Tax Rate

    n/a
    		 47.9%

    Stock Price Statistics

    The stock price has increased by -47.08% in the last 52 weeks. The beta is 1.17, so GoodRx's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.17

    52-Week Price Change

    n/a
    		 -47.08%

    50-Day Moving Average

    n/a
    		 4.26

    200-Day Moving Average

    n/a
    		 5.16

    Relative Strength Index (RSI)

    n/a
    		 57.86

    Average Volume (20 Days)

    n/a
    		 1,478,014

    Income Statement

    In the last 12 months, GoodRx had revenue of 792.32M and earned 16.39M in profits. Earnings per share was 0.04.

    Revenue

    n/a
    		 792.32M

    Gross Profit

    n/a
    		 744.11M

    Operating Income

    n/a
    		 65.85M

    Net Income

    n/a
    		 16.39M

    EBITDA

    n/a
    		 153.92M

    EBIT

    n/a
    		 84.38M

    Earnings Per Share (EPS)

    n/a
    		 0.04
    Full Income Statement

    Balance Sheet

    The company has 448.35M in cash and 543.39M in debt, giving a net cash position of -95.04M.

    Cash & Cash Equivalents

    n/a
    		 448.35M

    Total Debt

    n/a
    		 543.39M

    Net Cash

    n/a
    		 -95.04M

    Retained Earnings

    n/a
    		 -1.44B

    Total Assets

    n/a
    		 1.3B

    Working Capital

    n/a
    		 436.82M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 183.89M and capital expenditures -70.35M, giving a free cash flow of 113.55M.

    Operating Cash Flow

    n/a
    		 183.89M

    Capital Expenditures

    n/a
    		 -70.35M

    Free Cash Flow

    n/a
    		 113.55M

    FCF Per Share

    n/a
    		 0.29
    Full Cash Flow Statement

    Margins

    Gross margin is 93.91%, with operating and profit margins of 8.31% and 2.07%.

    Gross Margin

    n/a
    		 93.91%

    Operating Margin

    n/a
    		 8.31%

    Pretax Margin

    n/a
    		 3.97%

    Profit Margin

    n/a
    		 2.07%

    EBITDA Margin

    n/a
    		 19.43%

    EBIT Margin

    n/a
    		 8.31%

    FCF Margin

    n/a
    		 14.33%

    Dividends & Yields

    GDRX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 0.91%

    FCF Yield

    n/a
    		 6.33%
    Dividend Details

    Analyst Forecast

    The average price target for GDRX is $6, which is 35.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $6

    Price Target Difference

    n/a
    		 35.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 9
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 1.34

    Graham Upside

    n/a
    		 -69.82%

    Scores

    Altman Z-Score

    n/a
    		 0.92

    Piotroski F-Score

    n/a
    		 8

    Add to Watchlist